Literature DB >> 6971154

Use of cloned populations of mouse lymphocytes to analyze cellular differentiation.

G Nabel, M Fresno, A Chessman, H Cantor.   

Abstract

We describe a method for generation of homogeneous cell populations that each arise from clonal expansion of cells at a discrete stage of differentiation within a single lineage. We have used this to produce continuously propagatable lymphocyte clones. Each clone represents a cell at a progressive stage of thymus-dependent cellular differentiation. These cloned cells bear stable surface membrane glycoproteins characteristic of precursor cells and mature progeny; conditions allowing maximal cloning efficiencies for each cell type (10-85%) have been established. Mature lymphocyte clones continue to express specialized function and provide material for biochemical analysis of T lymphocyte functions; one fully differentiated clone from the "inducer" lymphocyte set synthesizes a molecule that activates other lymphocytes to secrete immunoglobulin. This activity is associated with a highly purified molecule having a molecular weight of 45,000 daltons and an isoelectric point of approximately 6.0. This molecule, together with clones of precursor and mature T lymphocytes, may provide a system to further study the mechanisms of gene activation during cellular differentiation.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6971154     DOI: 10.1016/0092-8674(81)90266-x

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  22 in total

1.  Isolation and characterization of a mouse interleukin cDNA clone that expresses B-cell stimulatory factor 1 activities and T-cell- and mast-cell-stimulating activities.

Authors:  F Lee; T Yokota; T Otsuka; P Meyerson; D Villaret; R Coffman; T Mosmann; D Rennick; N Roehm; C Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

2.  Cloning of two genes that are specifically expressed in activated cytotoxic T lymphocytes.

Authors:  C G Lobe; C Havele; R C Bleackley
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

3.  rpt-1, an intracellular protein from helper/inducer T cells that regulates gene expression of interleukin 2 receptor and human immunodeficiency virus type 1.

Authors:  R Patarca; G J Freeman; J Schwartz; R P Singh; Q T Kong; E Murphy; Y Anderson; F Y Sheng; P Singh; K A Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

Review 4.  Neoplastic cells as targets of spontaneously cytotoxic lymphocytes: studies with natural killer-like cell lines.

Authors:  A E Lagarde
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

5.  Alloreactive T-cell clones. Ly phenotypes predict both function and specificity for major histocompatibility complex products.

Authors:  A Rao; W J Allard; P G Hogan; R S Rosenson; H Cantor
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

6.  Sequential expression of new gene programs in inducer T-cell clones.

Authors:  G J Freeman; C Clayberger; R DeKruyff; D S Rosenblum; H Cantor
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

7.  Intercellular communication and cell cooperation in growth control of T-lymphocytes.

Authors:  J H Peters; W J Müller-Hermes
Journal:  Biophys Struct Mech       Date:  1982

8.  Isolation and characterization of a mouse cDNA clone that expresses mast-cell growth-factor activity in monkey cells.

Authors:  T Yokota; F Lee; D Rennick; C Hall; N Arai; T Mosmann; G Nabel; H Cantor; K Arai
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

9.  Azelastine and allergen transduction signal in MC9 mast cells.

Authors:  K Fanous; R P Garay
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-11       Impact factor: 3.000

10.  Multiple biologic activities of a cloned inducer T-cell population.

Authors:  G Nabel; J S Greenberger; M A Sakakeeny; H Cantor
Journal:  Proc Natl Acad Sci U S A       Date:  1981-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.